Identification and characterization of eukaryotic initiation factor 5A-2
about
Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instabilityPosttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modificationThe post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A)Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modificationeIF5A isoforms and cancer: two brothers for two functions?A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformationFunctional significance of eIF5A and its hypusine modification in eukaryotesSuppression of exogenous gene expression by spermidine/spermine N1-acetyltransferase 1 (SSAT1) cotransfection.Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancerDifferential expression of eIF5A-1 and eIF5A-2 in human cancer cells.Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.Deoxyhypusine synthase haploinsufficiency attenuates acute cytokine signaling.Loss of elongation factor P disrupts bacterial outer membrane integrityElongation factor P mediates a novel post-transcriptional regulatory pathway critical for bacterial virulenceBiological Relevance and Therapeutic Potential of the Hypusine Modification System.Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.The translation factor eIF5A and human cancer.Cancer chemoprevention locks onto a new polyamine metabolic target.Roles of eukaryotic initiation factor 5A2 in human cancer.The effect of selenium enrichment on baker's yeast proteomeGC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cellsExpression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.EIF5A2 is a novel chemoresistance gene in breast cancer.Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion.The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosisDown-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells.Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.Eukaryotic translation initiation factors and cancer.Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma.Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.DHPS tetramer synthesizes Dhp-K50-EIF5A from EIF5A and spermidineDOHH:Fe2+ hydroxylates Dhp-K50-EIF5A to form Hyp-K50-EIF5AKnockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.Interactions of elongation factor EF-P with the Escherichia coli ribosome.The Role of Acetylation in the Subcellular Localization of an Oncogenic Isoform of Translation Factor eIF5A
P2860
Q21261294-C59F37DC-FE09-4225-8E9F-1ADA123FB93BQ24648365-A84ABDA0-D2AB-4FD4-A1AC-F710E81F7F9AQ24649859-608E1ACA-C767-4880-98B3-C9EF24B34AAEQ24650882-98549CF3-9F25-445D-8406-56C00ED80D48Q26830163-4B34FC6D-D38E-41A8-86F2-4A9F080DA64CQ28510855-9CDA8CA7-58EE-4909-8977-7D4E13489F00Q33691772-3F2ADE8A-50C7-4CCD-833E-137B7B8E18D9Q33832683-3BBA130E-5D8E-4472-81BD-421676AE46FBQ34019744-1537A65E-FA5D-4DCB-AA31-01950ED400A7Q34095605-DCFC717E-39B6-4B59-B222-436E9C272DFBQ34137202-FC4BD107-7462-449B-B994-FA32092BFCFAQ34345765-81074ECB-8B3F-4EA5-B90D-DADACF757B08Q34499945-DC82880E-0491-41D9-9FEF-BCD5871762DEQ34515582-D58D83D1-7E3B-4EFF-A717-01503DDE3BA8Q34965348-11260D8D-1AD7-413E-BB48-6EA529023DBEQ35002343-BCDF9E5A-67A4-43F7-BDD8-B19F537AA134Q35668094-B92F4A9A-91ED-4BAA-9834-AC7B70590E72Q35693689-F7E7877D-5EAD-4ABE-ADB6-63AF428EB9EAQ35883784-C7B19154-21E3-49F9-A752-CCCC10EB3ECAQ36109579-47E9CBD6-B6D6-4CFC-BD4E-8ACEB6E7A170Q36519353-778E5919-BFDC-44E9-B94B-7783222B3370Q37681944-22AB28B9-5B92-400F-83C6-A62BDD7137ABQ38163977-B18BCE13-BC17-4FA0-9B63-476CE1F5CCB1Q38499986-771BDC10-AA35-4AF9-A3A5-B9426A2804E2Q38701796-A8F493B6-0E2E-4AB6-AD96-D16A6F942A37Q38843125-4ECEC65D-8864-4396-BB39-E32C326F5573Q39014521-8F27CF63-7994-4E98-BB00-292FC143B37AQ39068047-A91367FC-41C7-4CC2-9696-63C727650BC1Q39129140-430C908F-5840-4D7C-9FE2-8827CA2D0638Q39144255-7C3357FE-8855-4335-8D1B-DAB69C4AB9F2Q39380134-30F1383A-28D0-4463-82F0-7080A7EECCA4Q39400409-B32E44EF-6570-41F4-BAFE-6F3E3835AF2DQ42031208-861FC118-8191-4EB4-B5EC-0AD1EDFF457FQ42639936-F430BF6A-1331-452B-A758-8C5CC9229748Q47280262-2C682DF3-8193-4997-8E4D-3E922FAAB221Q50296151-8EEFD19A-C7E3-4607-A444-D4D9F517E262Q50296153-3C3B9D28-042B-44A3-97ED-9635540ADBBDQ52655137-BB05CD98-C10A-43AC-A7C0-6DD2A13F0EA2Q54427945-F4FC0F3F-20B7-48CB-8098-271170A4CA67Q57228540-A6611E8E-0715-460C-8BCC-31DF592D2CB3
P2860
Identification and characterization of eukaryotic initiation factor 5A-2
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Identification and characterization of eukaryotic initiation factor 5A-2
@ast
Identification and characterization of eukaryotic initiation factor 5A-2
@en
Identification and characterization of eukaryotic initiation factor 5A-2
@en-gb
Identification and characterization of eukaryotic initiation factor 5A-2
@nl
type
label
Identification and characterization of eukaryotic initiation factor 5A-2
@ast
Identification and characterization of eukaryotic initiation factor 5A-2
@en
Identification and characterization of eukaryotic initiation factor 5A-2
@en-gb
Identification and characterization of eukaryotic initiation factor 5A-2
@nl
prefLabel
Identification and characterization of eukaryotic initiation factor 5A-2
@ast
Identification and characterization of eukaryotic initiation factor 5A-2
@en
Identification and characterization of eukaryotic initiation factor 5A-2
@en-gb
Identification and characterization of eukaryotic initiation factor 5A-2
@nl
P2093
P2860
P921
P3181
P1433
P1476
Identification and characterization of eukaryotic initiation factor 5A-2
@en
P2093
C Allen Henderson
Edith C Wolff
Hans E Johansson
John W B Hershey
Myung Hee Park
Paul M J Clement
Zandra A Jenkins
Zeljka Smit-McBride
P2860
P304
P3181
P356
10.1046/J.1432-1033.2003.03806.X
P407
P577
2003-11-01T00:00:00Z